Natera

Biotechnology

Natera developed cell-free DNA testing for prenatal screening, organ transplant rejection monitoring, and cancer detection. The company's Panorama test revolutionized non-invasive prenatal testing, providing accurate genetic information without amniocentesis risks. Natera's platform technology demonstrates the power of analyzing DNA fragments circulating in blood.